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ABSTRACT  Mutations  have  been  introduced  into  the  cloned  DNA  sequences  coding  for 
influenza virus  hemagglutinin  (HA),  and the  resulting mutant genes have  been expressed  in 
simian  cells  by the use of SV40-HA recombinant viral  vectors.  In this  study we analyzed the 
effect  of specific  alterations  in  the  cytoplasmic  domain  of the  HA  molecule  on  its  rate  of 
biosynthesis and transport, cellular localization, and biological activity. Several of the mutants 
displayed abnormalities  in the  pathway of transport from  the endoplasmic  reticulum  to the 
cell surface. One mutant HA remained within the endoplasmic reticulum; others were delayed 
in  reaching the Golgi  apparatus  after core glycosylation  had  been  completed  in  the  endo- 
plasmic  reticulum,  but then progressed  at a normal rate from the Golgi apparatus to the cell 
surface; another was delayed in transport from the Golgi apparatus to the plasma membrane. 
However, two mutants were indistinguishable  from wild-type  HA in their rate of movement 
from the endoplasmic reticulum through the Golgi apparatus  to the cell surface. We conclude 
that  changes  in  the  cytoplasmic  domain  can  powerfully  influence  the  rate  of  intracellular 
transport and the efficiency  with which  HA reaches  the cell surface.  Nevertheless,  absolute 
conservation  of  this  region  of  the  molecule  is  not  required  for  maturation  and  efficient 
expression  of a biologically active  HA on the surface  of infected cells. 
An intriguing question in cell biology concerns the nature of 
the mechanisms governing the routes of transport of newly 
synthesized glycoproteins within eucaryotic cells.  Such pro- 
teins have a  number of alternative destinations in the cell: 
they  may be  retained  in  the  endoplasmic reticulum  or be 
transported to the Golgi apparatus; then they may be retained 
in the Golgi apparatus or be forwarded to other intracellular 
organelles or to the cell surface. Furthermore, different pro- 
teins  move along these  pathways at different  rates (1).  In 
epithelial  cells  that  have specialized apical and  basolateral 
membranes, a protein destined for the cell surface may also 
undergo  additional  sorting  to  its  appropriate  location  (2). 
However, little is known about the  factors that govern the 
intracellular rate of movement of proteins and guide them to 
their correct destinations. 
In recent years the amino acid sequences of a number of 
integral  membrane  proteins  have  been  determined,  either 
directly by use of the techniques of classical protein chemistry 
or indirectly  by analysis of the  DNA  sequences  of cloned 
copies  of their  genes.  These  proteins include  those  found 
naturally on eucaryotic cell  membranes, and  virally coOed 
polypeptides whose biosynthesis uses host cell processes and 
enzymes for their translation, translocation across the mem- 
brane  of the  rough  endoplasmic  reticulum,  glycosylation, 
maturation, and transport through the cell. Eucaryotic mem- 
brane proteins of this major class share characteristic struc- 
tural  features.  The  nascent precursor polypeptides have at 
their amino-terminus a short signal sequence of hydrophobic 
amino acids required for the association of the nascent poly- 
peptide chain with the membrane of the endoplasmic reticu- 
lure before translocation of the growing polypeptide across 
the lipid bilayer (3-6). After cleavage of the signal peptide and 
post-translational  modification,  the  mature  glycoproteins 
consist of (a) an ectodomain, which has receptor or enzymatic 
function and contains the carbohydrate side chains and anti- 
genic epitopes of the molecule (7-9); (b) at least one stretch 
of 20-30 contiguous hydrophobic amino acids that traverses 
the lipid bilayer and anchors the protein in the membrane (5, 
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varies both in amino acid sequence and in length (5) and lies 
on the cytoplasmic side of the plasma membrane. Although 
functions have been mapped to the first two domains, few if 
any functional roles have been  unambiguously assigned to 
the cytoplasmic domains of membrane glycoproteins. 
The hemagglutinin (HA) J glycoprotein of influenza virus 
shares the characteristic structural features described above. 
The  wealth  of knowledge  amassed  about  its  biosynthesis, 
structure, and function (for review see reference 12) makes it 
an ideal candidate for site-specific mutagenesis experiments 
aimed at elucidating the function of the various domains of 
the molecule. HA is naturally encoded by an RNA genome 
that is not amenable to in vitro mutagenesis. However, the 
HA gene from the A/Japan/305/57  strain of influenza virus 
has been cloned and sequenced (13). When this HA cDNA is 
introduced into eucaryotic cells by the use of vectors derived 
from SV40,  it is expressed with high efficiency into a  fully 
glycosylated protein that is displayed  on the surface of the 
infected cell in a  form indistinguishable from that found in 
influenza virus-infected cells (14). Our previous studies with 
a deletion mutant of HA that lacks the sequences coding for 
the carboxy-terminal transmembrane anchor and the cyto- 
plasmic  tail  showed  that  neither  region  was  essential  for 
expression  and  transport to  the  cell  surface,  although  the 
mutant  protein  was  then  secreted  into  the  medium  (15). 
However, the rate of transport of this mutant HA between 
the endoplasmic reticulum and the Golgi apparatus was sig- 
nificantly slowed. Initially we proposed that this might reflect 
differences in the efficiency with which the membrane-bound 
and luminal forms of the protein are sequestered in transport 
vesicles that travel from the rough endoplasmic reticulum to 
the Golgi apparatus (15). However, we subsequently observed 
that  a  chimeric  protein  that  has  the  transmembrane  and 
cytoplasmic domains of glycoprotein C  of Herpes virus at- 
tached to the external domain of HA is transported from the 
endoplasmic reticulum to the Golgi  apparatus at the same 
slow rate, despite being firmly anchored in the lipid bilayer. 
The  chimeric  protein  is  eventually  displayed  on  the  cell 
surface in an antigenic and functionally active form (unpub- 
lished  results).  These  results  taken  together  suggested  that 
sequences important for efficient transport of HA might reside 
within  either  the  transmembrane or cytoplasmic domains. 
Because the carboxyl-terminal tail of the molecule is exposed 
on the cytoplasmic face of the membrane it has an opportu- 
nity to interact with host cell proteins that may be involved 
in  controlling or facilitating intracellular transport.  In  this 
paper we have investigated the role of the cytoplasmic tail of 
HA by analyzing the effect of alterations in this domain on 
the intracellular transport of the molecule. Our results, to- 
gether with those obtained from similar studies with other 
eucaryotic glycoproteins (16-20),  are discussed  in terms of 
possible  mechanisms by  which  glycoproteins  move  within 
eucaryotic cells. 
MATERIALS  AND  METHODS 
Recombinant DNA Techniques:  Buffers and reaction conditions 
for restriction enzymes, T4 DNA  ligase, and the Klenow fragment of DNA 
polymerase I were those listed by the commercial source, New England Biolabs 
(Beverly, MA). Oligonucleotides containing the Cla I and Bam HI restriction 
sites were obtained from Collaborative Research Inc. (Lexington, MA). Isola- 
t Abbreviations used in thispaper: bp, base pair; endo H, endoglycosi- 
dase H; HA, hemagglutinin; RSV, Rous sarcoma virus. 
tion of DNA fragments and preparation of plasmid DNAs were carried out as 
described previously described (21).  Transformation of Escherichia coli strain 
DH- l was carried out according to Hanahan (22). 
Mutagenesis by Random Insertion of Linkers:  We  used  the 
procedure of Shortle (23) with minor variations to introduce linkers containing 
a Cla I site at random positions in plasmid pTl  (see Fig.  1A).  This plasmid 
consists of(a) the Eco RI-Bam HI restriction fragment of the HA gene, which 
encompasses sequences encoding the carboxy-terminal portion of the protein 
and (b) a vector from which sequences not essential for plasmid viability have 
been removed. Single nicks were introduced into supercoiled pTl  DNA (100 
~zg/ml in 50 mM Tris--HCl [pH 7.2], 5 mM MgCI2) by incubation for 30 min 
at room temperature with DNasel ( 120 ng/ml; Worthington Biochemical Corp., 
Freehold, N J) in the presence of ethidium bromide (100 gg/ml). A short gap 
was generated at the site of the single-strand break by incubation of the nicked 
DNA at 20"C for 15 min with M. luteus polymerase ! (0.25 U/#g DNA, Miles 
Laboratories Inc., Elkhart, IN) in 70 mM Tris-HCl (pH 8.0),  7 mM MgCI2 and 
1  mM 2-mercaptoethanol. To generate linear molecules the DNA was treated 
with mung bean nuclease (10 U/ml; P-L Biochemicals, Inc., Milwaukee, WI) 
at 37"C for 30 min in 30 mM sodium acetate (pH 4.6), 250 mM NaCI,  1 mm 
ZnCI2, and 5% glycerol. The linear molecules were then purified by agarose gel 
electrophoresis and ligated to Cla I linkers for transformation of E. coli strain 
DH-1.  Because an initial screening indicated that most of the resulting trans- 
formants  contained  plasmids that  lacked  a  Cla  I  site,  we  simultaneously 
inoculated a liquid culture with -104 different transformants, and purified and 
digested the mixture of plasmid DNAs with Cla 1. Linear DNA molecules were 
purified by agarose gel electrophoresis, recircularized, and used to transform E. 
coil  Plasmid DNAs  were  then  prepared  from  individual colonies and  the 
approximate site of insertion of the Cla I linker was determined by restriction 
enzyme analysis. The  HA sequences were purified from those plasmids that 
appeared to contain a  linker insertion within the nucleotides coding for the 
cytoplasmic domain and  cloned  into  MI3  phage  vectors (24)  for dideoxy- 
sequence analysis  by the chain termination technique (25). To introduce nearby 
in-frame termination codons, we had mutant pTl plasmids digested with Cla 
I and  Barn  HI  and  ligated to  a  70-base  pair (bp)  Taq  I-Barn  HI  fragment 
isolated from the Rous sarcoma virus (RSV) env gene (a gift from E. Hunter) 
(see Fig.  I B). To replace wild-type sequences in plasmid pSVEHA3 (14) with 
mutant HA sequences, we isolated the 650-bp Eco RI-Bam HI fragment from 
each mutant plasmid as shown in Fig.  1B.  At the same time, pSVEHA3 was 
partially digested with Eco RI and completely digested with Barn HI, as shown 
in Fig.  1 C. The large fragment was isolated and ligated with the 650-bp Eco 
RI-Bam  HI  mutant  HA fragment. This recircularized SV40-mutant  HA ge- 
nome was then digested with Barn HI and ligated to plasmid pXf3 (linearized 
with Barn HI) and used to transform E. coil 
Construction  of  Mutant  HAxpBR:  To  construct  mutant 
HAxpBR, we altered the termination codon  for the HA cDNA contained in 
plasmid pJ HBI 6 (14) and fused the HA coding sequences in frame to sequences 
derived from pBR322  (Fig.  1D).  Plasmid pJHBI6 was digested with Nde  I, 
which recognizes a single restriction site within HA DNA sequences that include 
the termination codon.  The recessed 3'-termini were then repaired with the 
Klenow fragment ofDNA polymerase 1. The plasmid was further digested with 
Barn HI and the larger DNA  fragment was isolated from an agarose gel. In 
parallel, pBR322 was digested with Hind Ill, repaired with Klenow, and digested 
with  Barn  HI  to generate a  350-bp  fragment, which was isolated and then 
ligatcd into the altered pJHBI6 plasmid described above. This ligation regen- 
erated a  Hind III restriction site at the point of fusion of HA sequences with 
pBR322.  We then excised these altered HA sequences from the plasmid by 
digestion with Sal  1 and  Bam  HI  and  used them  to  replace the  equivalent 
sequences in  pSVEHAK  to  produce  pSVEHAxpBR  (Fig.  I E).  pSVEHAK 
includes the early region of the SV40 genome, sequences coding for the HA, 
and a  plasmid, pKSB, cloned into the Kpn I site in the late region of SV40. 
pKSB is a derivative of pXf3 (21), which lacks both the Sal  I and  Barn  HI 
restriction sites, and contains a unique Kpn I restriction site. 
Generation of SV40-HA Virus Stocks and Infection of Simian 
Cells:  50 gg plasmid DNA was digested with Barn HI (or Kpn 1 in the case 
of pSVEHAxpBR), and the larger fragment, corresponding to the SV40-mutant 
HA recombinant genome, was isolated by agarose gel electrophoresis, recircu- 
larized under dilute Iigation conditions (3 vg/ml), and transfected into subeon- 
fluent monolayers of CVI cells together with an equal amount of helper virus 
d11055 (26).  60 mm dishes of cells were washed twice with phosphate-buffered 
saline (PBS)  and once with Tris-buffered saline and then treated with 0.25 ml 
of a solution containing DNA (75 ng SV40-HA recombinant genome and 75 
ng d11055) and DEAE-Dextran (l mg/ml) (27) in Tris-buffered saline for l  h 
at 37"C.  The DNA solution was then removed, and cells were washed gently 
once with Tris-buffered saline and once with PBS then incubated in Dulbecco's 
Modified Eagle's medium and 10% fetal calf serum in the presence of 100 ~,M 
chloroquine (28) for 3-4 h. Ceils were then washed three times with Dulbecco's 
modified  Eagle's medium  and  maintained  in  Dulbecco's  modified  Eagle's 
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with  the supernatant medium was  frozen,  thawed,  and  sonicated.  The cell 
extracts were  then  passaged  on  fresh  monolayers of CVI  cells in  order to 
develop high-titer  virus stocks used for expression of the mutant HA constructs. 
Hemagglutination  Assay:  42  h  after infection  with recombinant 
SV40-mutant  HA virus stocks, monolayers of infected CVI cells were washed 
twice with PBS, and guinea pig erythrocytes  (2 ml of a  1% solution of in PBS) 
were added. After 15 min at room temperature, the monolayers were washed 
with PBS and examined. 
Indirect Immunofluorescence:  Monolayers  of CVl cells were in- 
fected with SV40-HA virus stocks containing recombinant genomes encoding 
mutant and wild-type HA molecules. Cells growing on glass slides were taken 
at 42  h  postinfection  and fixed with 3.7% paraformaldehyde in PBS  for  10 
rain, quenched with 50 mM ammonium acetate, and washed extensively with 
PBS containing 0.25% gelatin. Indirect immunofluorescent staining by use of 
rabbit anti-HA serum followed by goat anti-rabbit IgG conjugated  with rho- 
damine or fluorescein (Cappell Laboratories,  Cochranville,  PA) was performed 
as described previously (29). 
Other Assays:  Immunoprecipitation  and SDS PAGE were performed 
as previously described  (14),  and endoglycosidase  H (endo  H) digestion  was 
performed  as described previously  by Owen et al (30). 
Palmitate Labeling:  CVl cells infected with vectors expressing either 
wild-type  HA or HAxpBR  were  labeled for 4 h with  100 uCi  [3H]palmitate 
(New England Nuclear,  Boston, MA) in Dulbecco's  modified  Eagle's medium 
then processed for immunoprecipitation  by the use of anti-HA serum (31). 
RESULTS 
Construction of Mutant HA Genes Coding for 
Proteins with Altered Cytoplasmic Tails 
The carboxyl-terminal hydrophilic region of  the HA protein 
is only 10 amino acids long, and four of the five final residues 
are absolutely conserved among HAs from different influenza 
virus subtypes (12). To explore the possibility that this region 
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in  intracellular  transport,  mutations have been  introduced 
into the  nucleotide  sequence encoding the cytoplasmic do- 
main. 
Most of the mutants were constructed by deletion/insertion 
mutagenesis (23).  The mutagenesis procedure is described in 
Fig.  1 and in Materials and Methods. A restriction fragment 
containing sequences coding for the 3' end of the HA gene 
was cloned into a plasmid from which nucleotide sequences 
not  essential  for plasmid viability had  been  removed.  We 
introduced nicks randomly into the supercoiled plasmid using 
DNase  I  in  the  presence  of ethidium  bromide.  We  then 
generated a short gap at the site of the single-strand break by 
incubating  the  nicked  DNA  with  M.  luteus  polymerase I. 
Treatment with  single  strand  exonuclease generated linear 
molecules to which were ligated synthetic linkers that con- 
tained  the  recognition  sequence  for the  restriction  enzyme 
Cla [. This procedure should yield closed circular molecules 
that have suffered a  small deletion at the site of the initial 
nick and an insertion of a  Cla I linker. The population of 
mutated plasmids was used to transform E. coli strain DH l, 
and  plasmid  DNAs  from  individual  transformants  were 
screened for the presence of a unique Cla I restriction site in 
the  sequences  coding  for the  cytoplasmic tail  of the  HA 
molecule. The DNA sequence of such clones was determined 
by the chain termination technique (25). 
One clone (HA164) contained a Cla I linker exactly at the 
junction  of the  sequences  coding  for the  anchor  and  tail 
domains of HA. The reading frame distal to the mutation was 
altered so that a novel cytoplasmic tail  16 amino acids long 
was generated. Five other clones that contained Cla I linkers 
within the region of interest were identified. However, in all 
cases the distal reading frame was altered so that the coding 
sequences extended far into plasmid or SV40 DNA before a 
termination signal was encountered. To overcome this prob- 
lem, we replaced the sequences between the Cla I and Bam 
HI sites  of the  mutant  clones  by a  70-bp  DNA  fragment 
isolated from the RSV env gene (32) by digestion with Taq I 
and Bam HI. This fragment codes in one reading frame for 
the authentic cytoplasmic tail of the env glycoprotein and in 
the others for Glu-Arg-STOP and Lys-Asp-Asp-STOP. It was 
therefore used to introduce terminators in all three reading 
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FIGUre  1 (facing page and above)  Construction  of mutants in the carboxyl-terminal  domain of HA: (A) random insertion of 
linkers; (B) insertion of termination codons; (D) construction of mutant HAxpBR; (C and E) substitution of altered HA sequences 
for wild-type sequences in the SV40-HA vector. Details are described in Materials and Methods. 
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Finally,  we took advantage of the fact that the restriction 
enzyme Nde I cuts the  HA sequence  once only within  the 
gene at the termination codon to generate  an additional type 
of mutant HA gene, which retains all wild-type sequences but 
lacks the  normal termination  codon (Fig.  1,  D  and  E  and 
Materials and Methods).  After fusion with sequences derived 
from pBR322, the mutant reads through these sequences to a 
termination  codon that  lies 48  nucleotides downstream  in 
distal plasmid sequences.  The mutant HA (HAxpBR) there- 
fore carries a cytoplasmic tail extension  that consists of wild- 
type sequences and an additional 16 amino acids specified by 
plasmid pBR322 DNA. 
The carboxyl-terminal amino acid sequence predicted from 
the DNA sequence of each mutant gene is compared with the 
wild-type sequence in Fig. 2. Mutant HA 71 has a cytoplasmic 
tail that is the same length as wild-type but is altered in three 
of the final  four residues  that are  conserved among all HA 
subtypes. HA 11 has a cytoplasmic tail that is only 3 amino 
acids  long  while  that  of HA164  is  16  amino  acids  long. 
HA152env is a chimeric glycoprotein with the authentic cy- 
toplasmic tail  of the RSV env glycoprotein substituting  for 
HA wild-type  sequences.  HA477env  retains all but the car- 
boxyl-terminal amino acid of wild-type HA and, in addition, 
is extended  by 22  amino acids  corresponding to  the  cyto- 
plasmic tail of the env glycoprotein.  HAxpBR retains all wild- 
type sequences but the tail is extended by sixteen novel amino 
acids. 
Construction  of SV40-HA Recombinant Viral 
Cenomes that Express Mutant Forms of HA 
After the  various mutations  had  been  verified  by DNA 
sequence  analysis, the Eco RI-Bam HI restriction  fragments 
that encompass the mutated region were used to replace the 
equivalent  wild-type DNA fragment in the SV40-HA recom- 
binant vector SVEHA3 (14). The resulting recombinant viral 
genomes were transfected into CV-1 cells and high titer viral 
stocks were prepared as described in Materials and Methods. 
The  presence  of mutant  viral  genomes was  confirmed by 
restriction  enzyme digestion  and gel  electrophoresis  of ex- 
tracted  viral  DNA (33)  (results  not  shown).  In  each  case, 
~50% of  the viral DNA extracted  from cells infected with the 
high titer stocks consisted of  HA-SV40 recombinant genomes; 
the remainder was the genome of the helper  virus  d11055. 
No rearranged viral genomes were detected. 
The amounts of HA antigen present  in CV-1 cells at late 
times after infection with the mutant and wild type HA-SV40 
recombinants were  quantitated  by solid-phase  radioimmu- 
noassay  and  analyzed  by  immunoprecipitation  and  SDS 
PAGE. With the exception of HAxpBR, all mutants produced 
amounts of HA antigen comparable to that expressed  from 
the original SVEHA3 (wild-type) recombinant vector, i.e., -5 
x  10  s molecules  per infected  cell (14). HAxpBR  produced 
slightly less HA than did the other mutants-- -3-4 x  108 
molecules  per infected  cell. In all cases, HA was detectable 
only in extracts of  the infected cells and not in the supernatant 
medium. Thus,  none of the altered genes coded for a secreted 
form of the HA. 
The sizes of the mutant HAs were analyzed by electropho- 
resis through SDS-polyacrylamide gels after immunoprecipi- 
ration with  anti-HA serum of extracts  of infected  cells that 
had  been  labeled  with  [35S]methionine  in  the  presence  or 
absence of tunicamycin (34). In some cases, the radiolabeled 
immunoprecipitates were treated with trypsin to cleave HA 
into  HA1  and  HA2  subunits  (35)  before  analysis  by SDS 
PAGE. The amino-terminal HAl subunits of all the mutants 
displayed  mobilities  that  were  indistinguishable  from each 
other and from that of wild-type  HA I. However,  the HA2 
subunits  of  several  mutants  (HA164,  HA477env,  and 
HAxpBR)  displayed  mobilities  that  were  slightly  different 
from that of HA2 derived  from wild-type HA. In every case, 
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FIGURE  2  Comparison  of carboxyl-terminal  amino  acid sequences  of wild-type  and  mutant  HA proteins.  Amino  acids to the  left 
of  the  dotted  line  are  part  of  the  membrane-spanning  region  and  those  to  the  right  make  up  the  cytoplasmic  domain.  The 
placement  of this  boundary  has  been  deduced  by the  alignment  of this  region of the A/Japan/305/57  strain  with that of the  HAs 
of other  influenza  strains.  -Asn- coincides  with  the  positions  of a  charged  residue  (-Arg- or  -Lys-) in  those  strains.  Amino  acids 
shown  in capital  letters correspond  to altered  residues. 
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alteration  in  the  carboxyl-terminal region  of the  molecule 
(results not shown). 
Localization of Mutant HA Proteins 
by Immunofluorescence 
The cellular distribution  of the  altered  HA  proteins was 
examined by indirect immunofluorescence of monolayers of 
infected CV-1 cells. Fig. 3 shows examples of results obtained 
with cells that had been permeabilized and stained so as to 
reveal both intracellular and cell surface forms of HA. Cells 
infected with any of the mutants except HAl64 and HAxpBR 
displayed a  strong perinuclear staining, which probably cor- 
responds to elements of the endoplasmic reticulum and to the 
Golgi  apparatus  (36).  In  addition,  we  saw  a  more diffuse 
staining, which represented HA molecules that had accumu- 
lated at the cell surface. Intact cells displayed only this diffuse 
surface staining (results not shown).  This pattern of surface 
and  intracellular  fluorescence  is  identical  to  that  seen  in 
influenza virus-infected cells or CV-1  cells  infected with the 
SVEHA3  recombinant  vector that  expresses wild-type HA 
(14). Such a pattern is typical of glycoproteins synthesized in 
the endoplasmic reticulum and transported to the cell surface 
via the Golgi apparatus. 
Cells infected with mutant HAxpBR showed a  pattern of 
FIGURE  3  Indirect immunofluorescent labeling with corresponding erythrocyte-binding pattern of wild-type HA and each of the 
mutant HAs in CVl  cells infected with SV40-HA recombinant viruses. ×  70. In the lower right corner are shown two enlargements 
(x 140) of HA164-infected cells. The arrows indicate the same cells, which have been enlarged to illustrate the vesicular pattern 
typically seen in an HA164 infection. 
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the mutant protein in the endoplasmic reticulum. Although 
some juxtanuclear  concentration  of  fluorescence  was  ob- 
served, a similar distribution of staining was seen in control 
experiments in  which  CV-1  cells  infected with  SV40  virus 
were treated with  an antibody that  specifically reacts with 
antigens localized in  the endoplasmic reticulum (37).  Cell- 
surface fluorescence was not observed, except in a  very few 
isolated cells (< 1 in 2,000). These data suggest that this mutant 
codes for a  protein that is blocked at an early stage in the 
transport pathway before its movement into the Golgi appa- 
ratus. 
Cells  infected  with  mutant  HA164 showed  a  pattern  of 
fluorescence quite distinct from that of cells expressing wild- 
type HA. In addition to the reticular and perinuclear staining 
seen in cells infected with wild-type virus, a morphologically 
distinct set of heterogeneously sized vesicles reacted strongly 
with the anti-HA sera. The vesicles were concentrated near 
the nucleus but a few were found throughout the cytoplasm 
of the infected cell, spreading as far as the cell periphery. The 
staining pattern coincided with neither of those we obtained 
using antisera directed against endoplasmic reticulum or ly- 
sosomes (37),  nor with the fluorescence seen using acridine 
orange which concentrates in vesicles having a  low endoge- 
nous pH (38). However the staining pattern did coincide with 
that we obtained using fluorescent labeled wheat germ agglu- 
tinin, which suggests that they may be derived from the Golgi 
or a post-Golgi compartment (results not shown).  An addi- 
tional diffuse cell surface fluorescence was detectable in ~20% 
of the cells in the infected population, indicating that mole- 
cules of HA164 can break through to the cell  surface. The 
minority of cells that displayed HA on their surface are those 
in  the  infected cell  population  that  stained  most intensely 
with anti-HA sera. This result suggests  that the block to the 
transport of HA164 to the cell surface may be overcome when 
concentration of intracellular HA reaches very high levels. 
Kinetics of Transport from the Endoplasmic 
Reticulum to the Golgi Apparatus 
An  early  post-translational  event  in  the  biosynthesis  of 
glycoproteins is the trimming of mannose-rich oligosaccha- 
rides, a process that begins in the smooth endoplasmic retic- 
ulum  and  is  apparently  completed  soon  after the  protein 
arrives in the Golgi apparatus (39,  40).  Mannose-rich oligo- 
saccharides can be removed from the nascent polypeptide in 
vitro  by  digestion  with  endo  H,  whereas  the  completely 
trimmed forms are resistant to this enzyme (41).  Thus, in a 
standard pulse-chase protocol, acquisition by a glycoprotein 
of resistance to endo H  provides a convenient and sensitive 
measure of the transit time from the endoplasmic reticulum 
into the cis Golgi apparatus. To determine whether alterations 
in the cytoplasmic tail of HA might affect the rate at which 
the nascent polypeptide is transported into the Golgi appara- 
tus, CV-1 cells infected with mutant virus stocks were pulse- 
labeled with [35S]methionine  for 10 min and then incubated 
in the presence of an excess of nonradioactive methionine for 
various periods.  Wild-type and mutant HAs were then im- 
munoprecipitated from cell extracts, incubated with endo H, 
and  separated on SDS-polyacrylamide gels.  The results are 
shown in Fig. 4 and summarized in Table I. 
According to  the  kinetics of acquisition  of resistance  to 
endo H, mutant HAs can be assigned to three groups. Two 
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of the  mutants  (HATI  and  HA152env) displayed  kinetics 
indistinguishable  from those of the wild-type protein. Both 
mutant and wild-type proteins became entirely resistant to 
the enzyme within 30 min of labeling with [35S]methionine. 
The acquisition of resistance to endo H  by mutants HAll, 
HA477env, and HA164 is somewhat delayed. In each case, 
-20% of  the HA population remained sensitive to the enzyme 
at the end of a 30-min labeling. Finally, the HAxpBR glyco- 
protein remained completely sensitive to digestion with endo 
H  even 8 h after the initial labeling, a result consistent with 
the  observation  (Fig.  3)  that  these  mutant  molecules  are 
retained in the endoplasmic reticulum or a  pre-Golgi com- 
partment (56).  Nevertheless, some post-translational modifi- 
cation still took place; like wild-type HA, HAxpBR could be 
labeled with [3H]palmitate (results not shown). This finding 
is consistent with recent results indicating that when transport 
from the endoplasmic reticulum is blocked, addition of fatty 
acid side chains to the nascent polypeptide can occur (42). 
Expression of Mutant HA Proteins on the 
Cell Surface 
We monitored the appearance of the mutant HA proteins 
at the cell surface qualitatively by binding of erythrocytes to 
infected cell  monolayers and quantitatively by assaying the 
proportion of cell-associated HA that was sensitive to diges- 
tion by trypsin added to the medium above the infected cells. 
The hemagglutinating activity displayed by cells  infected 
for 42 h with the various mutant viruses is shown in Fig.  3. 
Erythrocytes bound densely to 90-100% of the cells infected 
with  mutants HA152env, HA71, HA477env, and HAll.  In 
this respect these mutants were indistinguishable from wild- 
type HA. By contrast, a maximum of 25% of the cells infected 
with HA164 bound erythrocytes, even at very late stages in 
the infection. The hemagglutinating cells probably correspond 
to those that were seen to display surface immunofluorescence 
(see above). To eliminate the possibility that the cells in the 
monolayer were not  uniformly infected, cells  infected with 
HA164 virus were prepared for immunofluorescent staining 
of SV40 T-antigen. Strong nuclear fluorescence typical of an 
SV40 infection was seen in _>90% of the cells. Finally, eryth- 
rocytes bound to <0.1% of cells infected with HAxpBR virus, 
a result consistent with the retention of the mutant protein in 
the endoplasmic reticulum. 
To compare the total amount of trypsin-sensitive HA pro- 
duced by the various mutants, infected cells were pulse-labeled 
with  [35S]methionine  for  10  min at 42  h  postinfection and 
then incubated for 1 or 2 h in serum-free medium containing 
an excess of nonradioactive methionine. For the last 15 min 
of the chase period, trypsin was added to the medium at a 
concentration (20 ~g/ml) sufficient to cleave HA at the cell 
surface into its two subunits,  HA1  and HA2. We analyzed 
radiolabeled proteins precipitated from cell extracts by anti- 
HA serum by SDS PAGE. With the exception of HAxpBR 
and HA164, all mutant HAs were cleaved into HA1 and HA2 
with an efficiency very similar to that displayed by wild-type 
HA.  However, no immunoprecipitable HAl  and  HA2 was 
detectable  in  extracts  prepared  from  cells  infected  with 
HAxpBR; severely reduced levels (~25% of wild-type levels) 
were detected in extracts of cells infected with HA164 (data 
not shown). Comparison of the time course of acquisition of 
endo H  resistance with the time course of the appearance of 
trypsin-sensitive HA at the cell surface indicated that, except FiGure  4  SDS PAGE of mutant HA proteins. CVI  cells, infected for 42 h with recombinant SV40-HA virus stocks, were labeled 
for 10 rain (I0") and then incubated in medium containing an excess of nonradioactive methionine for 30 min, I  h, and 2 h. Cell 
extracts were  prepared, and proteins were  immunoprecipitated with anti-HA serum, and treated with  endo H  as described in 
Materials and Methods. 
TABLI~  l 
Cellular Transport of Hemagglutinins  with Mutations in 
Carboxy- Terminal Domain* 
Translo- 
cation  Transport 
Type of  through  Transport from ER  from Golgi 
Hemagglutinin  ER  to Golgi  to surface 
HA wt  +  20 min  + 
HAxpBR  +  >8 h  - 
HAlt  +  1 h  + 
HA 477env  +  1 h  + 
HA 164  +  1 h  +/- 
HA 71  +  20-30 rain  + 
HA 152env  +  20-30 min  + 
* Cellular  transport  of  hemagglutinins with  altered  cytoplasmic  domains. 
Translocation through the endoplasmic reticulum (ER)  is measured by signal 
cleavage and the acquisition of mannose-rich oligosaccharides. Transport 
from the ER to the Golgi apparatus is given as the time required for newly 
synthesized protein to become resistant to treatment with  endo H and to 
acquire complex sugars in the Golgi apparatus. Transport from the Golgi 
apparatus to the surface is measured by erythrocyte binding and sensitivity 
to trypsin in the medium of infected cells (see Results). 
for HA164,  there  was  little  or  no  variation  in  the  rate  of 
movement of the wild-type and mutant proteins between the 
Golgi apparatus and the surface. 
DISCUSSION 
The pathway of transport of nascent membrane and secretory 
proteins from their site of synthesis in the rough endoplasmic 
reticulum to their destination in intracellular organelles or at 
the  cell  surface can  be divided  into  two  phases.  The  first, 
between the endoplasmic reticulum and the Golgi apparatus, 
appears to be shared by all newly synthesized membrane and 
secretory proteins destined for further transport (l, 43-46). 
The  second  phase,  from  the  Golgi  cisternae,  involves the 
routing of individual proteins along separate pathways to their 
final locations within and without the cell (46-52). Different 
proteins  can  be  transported  and  processed  at  significantly 
different rates even when they are synthesized in a single cell 
type (43-45,  47,  49).  In  all  cases  so  far  studied  the  rate- 
determining step(s) appear to lie in the first phase of transport 
before trimming of oligosaccharides is completed in the Golgi 
apparatus. Certain proteins are transported rapidly from the 
endoplasmic reticulum whereas others move slowly and asyn- 
chronously (1, 43-45, 47, 48,  50).  Even mutants of a single 
protein can show marked variations in processing times (l 5, 
16, 53). It is therefore likely that the polypeptides themselves 
contain  information that  determines their rate  of transport 
along the  first phase of the secretion pathway. By contrast, 
little variation in rate is associated with the route through the 
Golgi apparatus to the cell surface, so that irrespective of the 
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membrane and constitutively  secreted proteins  so far exam- 
ined move on to the cell surface at the same relatively rapid 
rate (43). 
We undertook the experiments  described  in this paper to 
explore the importance of the carboxyl-terminal  domain of 
HA during its biosynthesis  and transport.  Alterations  were 
made to the cDNA sequences coding for the cytoplasmic tail 
of the HA molecule. These HA genes specify mutant proteins 
in  which  the  carboxyl-terminal  amino  acids  have  been 
changed,  deleted,  extended,  or replaced  by the cytoplasmic 
tail  of the RSV  env glycoprotein.  The HA genes were then 
expressed  in CV-1 cells under the control of the SV40 late 
promoter and the effect of  the mutations on the transport and 
cellular  location of the altered  proteins  was analyzed.  The 
results are summarized in Table I, in which the mutants are 
ordered  according to the site of their defect in the transport 
pathway. 
The mutant HAxpBR  displayed  the earliest and most ex- 
treme defect in transport. This protein,  which has an intact 
cytoplasmic  tail  followed by an  additional  16 amino acids 
derived  from  normally  noncoding plasmid  sequences,  re- 
mains in the endoplasmic reticulum.  A comparable mutant 
of the vesicular stomatitis  virus G protein,  which contains a 
cytoplasmic tail extended to 38 amino acids from its normal 
length  of 29  residues,  is also  confined to the endoplasmic 
reticulum (16), as is a mutant of  vaccinia virus hemagglutinin, 
which has an uncharacterized  extension  of carboxyl-terminal 
sequences (18). At least in the case of HAxpBR, the failure to 
leave the  endoplasmic reticulum  cannot be  a  consequence 
merely  of an  increase  in  the length  of the cytoplasmic tail 
since mutant HA477env, whose tail is extended by 23 amino 
acids, is transported,  albeit slowly, to the Golgi apparatus  and 
cell surface.  Two other mutants of the vesicular  stomatitis 
virus G protein,  in which the entire cytoplasmic tail has been 
replaced by either  3 or 12 nonhomologous amino acids, are 
not transported beyond the endoplasmic reticulum (16). The 
type of  alteration  that most frequently results in major defects 
in transport involves the addition of novel  nonhomologous 
amino acid sequences  onto truncated or intact cytoplasmic 
tails (see also HA164, which is blocked at a post-Golgi appa- 
ratus  stage). The fact that these  novel  sequences  appear to 
poison transport raises  the  possibility  that  the  cytoplasmic 
tails of integral  membrane proteins,  although diverse  in  se- 
quence, may nevertheless be subject to quite strong evolution- 
ary constraints. 
The  second  group of mutants  codes  for HA  molecules 
whose  transit  between  the  endoplasmic reticulum  and  the 
Goigi  apparatus is slow and asynchronous, like that of the 
anchor-minus mutant of HA (15), but whose final disposition 
on the cell surface is like that of wild-type HA. In HAll  the 
final  10 amino acids  of wild-type  HA are  replaced  by the 
tripeptide  lle-Glu-Arg, whereas in HA477env the cytoplasmic 
domain is extended  by the  23  residues  of the homologous 
region of the RSV env glycoprotein. In phenotype both HA I 1 
and HA477env  resemble  mutants of the VSV G  protein in 
which  the terminal  16 residues  of the 29 amino acid  cyto- 
plasmic tail have been replaced by 3, 7, or 23 nonhomologous 
amino acids  (16). It is  interesting  that  the  rates  at  which 
mutants of this second group move fall within the wide range 
observed for different  normal cellular membrane and secre- 
tory proteins (43, 44, 47-49). 
The transport of mutant HA164 between the endoplasmic 
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reticulum and the Golgi  apparatus was also  somewhat de- 
layed. However, this mutant protein,  in which the wild-type 
cytoplasmic tail has been replaced by a novel sequence of 16 
amino acids, also displayed  a  major defect  in transport be- 
tween  the Golgi apparatus and the plasma membrane. The 
mutant protein,  which  has  undergone complete processing 
and terminal glycosylation, is sequestered in large vesicles that 
are  distinct  from lysosomes  and do not appear to have  an 
acid pH. In their size and shape, these vesicles resemble those 
observed in cells treated  with chloroquine (54) or in cells in 
which  transport  from  the  Golgi  apparatus  is  blocked  by 
lowering of the temperature to 20"C (55-57).  The best  hy- 
pothesis for the origin of  the vesicles in ceils containing HA 164 
is that they are abnormal or enlarged structures  derived from 
the Golgi apparatus or a post-Golgi compartment. 
Finally, mutants HA71 and HA152env were indistinguish- 
able in phenotype from wild-type HA. They were transported 
into the cell surface at the same rate as the wild-type protein 
and displayed the same patterns  of immunofluorescence and 
erythrocyte binding.  The cytoplasmic tail of HA 71 is exactly 
the same length as that of wild-type HA, but three of the four 
terminal amino acids have been altered  from Arg-lle-Cys-Ile 
to Ser-Ile-Glu-Arg. The fact that these amino acids are highly 
conserved among HAs of different  strains of influenza  virus 
(12) has led to speculation  that this  region  of the molecule 
may play a role in intracellular  transport of HA or assembly 
of virions.  It now seems  likely that the latter  of these  two 
hypotheses  is correct.  Although it is not surprising  that the 
minor alterations  in  HA71  should  have  little  effect  on  its 
transport,  the  fact that  HA152env  (whose  structure  is  very 
different from that of HA) displays a wild-type phenotype has 
more important implications.  The substitution  of the cyto- 
plasmic tail of the RSV env glycoprotein (22 amino acids) for 
the  cytoplasmic tail  (10  amino  acids)  and  the  last  seven 
residues of the transmembrane region of HA has no effect on 
the biosynthesis, rate of transport,  final location, or biological 
activity of the chimeric protein.  It is interesting that the wild- 
type env glycoprotein  is transported to the Golgi apparatus 
much more slowly (t~/2 =  2-3 h [53]) than is the HA152env 
chimera (11/2  =  20 rain).  Thus,  grafting the cytoplasmic  tail 
from one membrane protein to another does not impose the 
kinetics of transport of the donor on the recipient.  We con- 
clude that  the  carboxyl-terminal  region  cannot exclusively 
determine the rate at which  membrane proteins  move from 
the endoplasmic reticulum  through the Golgi  apparatus to 
the cell surface. 
The conclusions  from these  and previous  studies  on the 
rates  at which mutant forms of HA (15) and vesicular  sto- 
matitis  virus G (16) proteins  are transported through the cell 
may be summarized as follows: 
(a)  Mutations  in  the  carboxyl-terminal  cytoplasmic do- 
main frequently lead to a decreased rate of protein transport 
between the endoplasmic reticulum  and the Golgi apparatus 
without affecting subsequent  transport to the cell surface. (b) 
Gross deletion  of carboxyl-terminal  sequences or addition of 
novel  amino acids can halt the transport of a protein from 
the  endoplasmic  reticulum  or,  in  one  case,  from  a  Golgi 
apparatus-derived compartment. (c) Absolute  conservation 
of the sequence  of the carboxyl-terminal  domain is not re- 
quired  for efficient transport, since some mutants display  a 
phenotype that is indistinguishable  from wild type. (d) There 
is no obvious correlation  between the distribution  of charged 
and hydrophobic residues or the length of  the cytoplasmic tail and the behavior of a  protein in the transport pathway. (e) 
There is no dominant signal within the cytoplasmic domain 
that  determines  the  efficiency  or  rate  of transport  of the 
protein through the cell. 
These conclusions are consistent with data obtained from 
less-detailed studies of mutants of a number of other cellular 
and  viral  membrane glycoproteins.  For example,  truncated 
mutants  of the E2 glycoprotein of Semliki Forest  virus are 
transported  to the  cell  surface, despite  various deletions  of 
cytoplasmic tail  sequences (17),  Similarly, mutants without 
the carboxyl-terminal domain of the H-2 murine histocom- 
patibility antigen  can  be displayed  on the cell surface  in  a 
functional  form (19,  20).  Apparently these  mutations,  like 
many  of those  in  HA,  are  not  severe  enough  to  cause  a 
complete blockage of transport.  Whether they affect the rate 
at which the glycoproteins move to the plasma  membrane 
remains to be determined. 
Several  ideas  have  been  proposed  to  describe  how  the 
transport of glycoproteins through eucaryotic cells  might be 
facilitated or controlled (1,  5, 45-47,  58).  These models fall 
into two classes,  those that invoke interactions between the 
transported  protein  and  hypothetical cellular receptors and 
those that do not. Both classes can account for all the salient 
features of the transport pathway: the variable rates at which 
different proteins move, the separation of transported glyco- 
proteins from proteins that are endogenous to the organelles 
of  the secretion pathway, and the concentration of  transported 
proteins with  respect to the membrane of the endoplasmic 
reticulum  (59).  None of the models that  invoke a  receptor 
predicts the location  of the putative transport  signal  on an 
integral membrane protein,  i.e.,  whether it might be on the 
external domain, within the transmembrane region, or in the 
cytoplasmic tail.  Our data do not rule out receptor-mediated 
transport, but they do exclude the cytoplasmic tail as the sole 
recognition signal. 
In the absence of any definitive evidence for interaction of 
HA with receptor or carrier proteins, the simplest explanation 
of the  phenotypes of the  mutants  is that alterations  in the 
primary sequence of the cytoplasmic tail (or transmembrane 
region) can act directly to retard the movement of the mole- 
cule. For example, deletion or extension of the cytoplasmic 
tail  might  destabilize  interactions  between  the  three  trans- 
membrane domains of the HA trimer, which are thought to 
cross the lipid  bilayer as  stacked  alpha-helices.  This  might 
prevent  or delay  folding and  oligomerization of the  entire 
molecule--presumably a  prerequisite  for its movement. Al- 
ternatively,  the  disordered  transmembrane  structure  could 
retard  the  movement  of the  protein  in  the  plane  of the 
membrane or obstruct the incorporation of the protein into 
transport vesicles that shuttle it from the endoplasmic reticu- 
lum  to  (and  through)  the  Golgi  apparatus.  Totally  novel 
sequences such as those appended to the tail of HAxpBR or 
HA164  might  be  expected  to  cause  more disruption  than 
sequences  that  have  evolved as  cytoplasmic tails  on  other 
membrane proteins.  According to this hypothesis, substitu- 
tion or addition of the env cytoplasmic sequences might be 
expected to  have  comparatively little  effect on  the  rate  of 
transport of HA. 
Among all  the mutants so far analyzed, only HA164 dis- 
plays a defect in the second phase of the transport pathway, 
from the Golgi apparatus to the cell  surface.  Like the wild- 
type molecule, HA164  is fully processed and undergoes ter- 
minal glycosylation. However, instead of passing quickly from 
the trans-Golg~  to the cell surface, it becomes trapped in large 
vesicles that accumulate in the cytoplasm of the infected celt. 
Presumably these vacuoles are derived directly from the trans- 
Golgi by a process of abnormal budding. There are at least 
three possible ways to explain the phenotype of HA164. Either 
the mutant HA lacks a sorting signal that is normally used to 
guide wild-type HA into vesicles destined for the cell surface, 
or  the  alteration  in  the  cytoplasmic  sequences  of HA164 
interferes with the process of vesicularization itself in a way 
that causes aberrant structures to be formed; in addition, the 
novel tail could block the movement of the vesicles to their 
correct destination. Whatever the explanation, it is clear that 
the defect in HAl64 does not prevent transport of the mole- 
cule through the early phase of the transport pathway. This 
result shows that there are at least two different steps--one 
pre- and the other post-Golgi apparatus--at which the struc- 
ture of the cytoplasmic tail of HA can influence the transport 
of the molecule.  It remains to be established  whether these 
steps, which have been defined by the use of altered glycopro- 
tein  molecules,  play  controlling  roles  in  the  transport  of 
normal cellular and viral membrane proteins. 
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